Loading....
Monday, November 19, 2018
10:00 AM EST
This public meeting will gather key stakeholders including Scott Gottlieb, M.D., Commissioner of FDA, and Janet Woodcock, M.D., Director of FDA's Center for Drug Evaluation and Research, to discuss the potential utilization of clinical information gained from expanded access (investigational) protocols.
Discussions will cover multiple perspectives on how to approach data collection and improve EAPs.
U.S. Food & Drug Administration
White Oak Campus, Building 31, Great Room, 10903 New Hampshire Avenue
Silver Spring, MD 20993
Please arrive 30-45 minutes early to allow for security check at the front desk.
No liquids or weapons allowed in the building.
Bring a valid government-issued ID with photo. Name on ID must match registration details.
Non-U.S. residents must register at least 2 weeks prior to event.
All participants must enter through Building 1. More info on parking and security at FDA can be found here.
Box lunches and coffee available for purchase on-site.
,
Get in touch! or
Leveraging Real-World Treatment Experience from EA Protocols
Monday, November 19, 2018
U.S. Food & Drug Administration
White Oak Campus, Building 31, Great Room 10903 New Hampshire Avenue Silver Spring, MD
,
Get in touch! or
Leveraging Real-World Treatment Experience from EA Protocols
Monday, November 19, 2018
U.S. Food & Drug Administration
White Oak Campus, Building 31, Great Room 10903 New Hampshire Avenue Silver Spring, MD
,
Get in touch! or
Leveraging Real-World Treatment Experience from EA Protocols
Monday, November 19, 2018
U.S. Food & Drug Administration
White Oak Campus, Building 31, Great Room 10903 New Hampshire Avenue Silver Spring, MD
You're all set. A copy of your receipt will be emailed to you.
,
Get in touch! or